- Home
- XFOR vs GRVY Comparison
XFOR vs GRVY Comparison
Compare XFOR & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | GRVY |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | South Korea |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 399.1M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | XFOR | GRVY |
|---|---|---|
| Price | $4.39 | $62.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $25.20 | N/A |
| AVG Volume (30 Days) | ★ 583.2K | 20.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,263.94 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $53.12 |
| 52 Week High | $6.63 | $74.75 |
Technical Indicators
Market Signals| Indicator | XFOR | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 65.07 | 41.53 |
| Support Level | $3.38 | $62.10 |
| Resistance Level | $4.53 | $65.27 |
| Average True Range (ATR) | 0.24 | 2.28 |
| MACD | 0.14 | -0.43 |
| Stochastic Oscillator | 72.49 | 19.77 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.